A Clinical Trial to Evaluate the Effects of A Supplement on Supporting Signs of Metabolic Health

NCT07765394 | Completed

• 2 other identifiers: 20745legacy-20745
• Study Type: interventional
• Target: 40
• Locations: 1 country
• Sites: 1

Brief Summary

This study evaluates the effects of the Love Wellness supplement Hello Burn Activate on supporting metabolic health in adult females. The 12-week, single-arm, open-label, virtual trial will enroll 40 female participants aged 25-45 who are experiencing challenges with healthy weight management and body confidence. All participants will take one capsule of the test product daily in the morning with their first meal. Participants will complete self-reported questionnaires at Baseline, Week 4, Week 8, and Week 12 to assess changes in perceived metabolic health, body confidence, overall health, and well-being.

Conditions

Metabolic Health; Weight Management; Body Confidence; Gut Health

Outcome Measures

Primary Outcomes (1)

• Change in Perceived Metabolic Health

  Self-reported assessment of overall metabolic health via self-reported questionnaire

  Baseline, Week 4, Week 8, and Week 12

Secondary Outcomes (3)

• Change in Body Confidence

  Baseline, Week 4, Week 8, and Week 12

• Change in Overall Well-Being

  Baseline, Week 4, Week 8, and Week 12

• Change in Overall Health

  Baseline, Week 4, Week 8, and Week 12

Study Arms (1)

Hello Burn Activate

EXPERIMENTAL

Dietary Supplement: Hello Burn Activate

Interventions

Hello Burn Activate DIETARY_SUPPLEMENT

All enrolled participants take one capsule of Hello Burn Activate (containing heat-treated Bifidobacterium animalis lactis BPL1, inulin, vegetable capsule \[hypromellose, water\], and medium chain triglycerides) once daily in the morning with the first meal of the day for 12 weeks.

Hello Burn Activate

Eligibility Criteria

• Age: 25 Years - 45 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64)

You may qualify if:

• Be female.
• Be aged 25-45.
• Currently experiencing issues regarding healthy weight management.
• Currently experiencing issues regarding body confidence.
• Currently experiencing difficulty maintaining a weight management routine.
• Generally healthy - does not live with any uncontrolled chronic disease.
• Willing to refrain from taking any products, prescription medications, or supplements that target metabolic health during the test period.
• Willing to maintain their current diet, sleep schedule, and activity level for the duration of the study.
• Resides in the United States.

You may not qualify if:

• Anyone with pre-existing chronic conditions that would prevent participants from adhering to the protocol, including cancer, mental health disorders, history of serious illness in the last three months, history of substance abuse, or planned surgery during the study period.
• Anyone taking a prescription GLP-1 medication, including but not limited to Ozempic, Wegovy, or Mounjaro.
• Anyone taking a prescription anticoagulant ('blood thinner') medication.
• Anyone taking a prescription antibiotic.
• Anyone who drinks heavily (i.e., 8 or more alcoholic drinks per week for women or 15 or more alcoholic drinks per week for men).
• Any women who are pregnant, breastfeeding, or trying to conceive (or who will be at any point during the study period).
• Anyone participating in another research study within the next 12 weeks.
• Anyone unwilling to follow the study protocol.
• Anyone with any allergies or sensitivities to any of the study product ingredients.

Sponsors & Collaborators

• Love Wellness: lead
• Citruslabs: collaborator

Study Sites (1)

Citruslabs

Las Vegas, Nevada, 89101, United States

Location

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: SINGLE GROUP
• Sponsor Type: INDUSTRY
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: August 11, 2026
• First Posted: August 14, 2026
• Study Start: April 7, 2025
• Primary Completion: July 28, 2025
• Study Completion: July 28, 2025
• Last Updated: August 14, 2026

Record last verified: 2026-08

Locations

US (1)